BetterLife Pharma CEO Ahmad Doroudian joined Steve Darling from Proactive to share news their subsidiary, Altum Pharmaceuticals has signed an agreement with a European-based investor group for a non-brokered financing of up to 5 million dollars.
Doroudian says the financing will be in tranches starting in January. Altum is looking to advance the pre-clinical and clinical programs in providing potential treatment for COVID-19 and its variants.